SAN DIEGO – Medtrade exhibitor Resmed has acquired Medtrade exhibitor VirtuOx, an independent diagnostic testing facility (IDTF) for sleep, respiratory, and cardiac conditions. VirtuOx will operate as a fully owned subsidiary of Resmed following the transaction, continuing to serve partners and patients under its existing brand in the near term. The VirtuOx leadership team will remain in place and continue to drive the company’s growth and innovation strategy.
The acquisition reflects Resmed’s commitment to improving the way care is delivered—by making it more accessible, more coordinated, and more patient friendly. With VirtuOx’s at-home diagnostic services, Resmed will be better positioned to support patients earlier in their journey and help healthcare providers and homecare companies deliver care in a simpler, more connected way.
Medtrade exhibitor VirtuOx has a virtual testing platform that helps reduce barriers to diagnosis, offering fast, flexible, and affordable options for patients—particularly those with sleep-disordered breathing or other conditions that are often underdiagnosed.
For people suspected of having obstructive sleep apnea (OSA), a more streamlined, digital-first experience can make the difference between following through on testing and treatment—or falling out of the care pathway entirely.
“This is about creating a simpler, more connected pathway to care,” said Justin Leong, chief product officer at Resmed. “By integrating VirtuOx’s diagnostic capabilities into our ecosystem, we can help accelerate the time between evaluation and treatment, reduce drop-off, and help more people access the life-changing benefits of therapy for sleep apnea and related conditions.”
The acquisition strengthens Resmed’s ability to partner with healthcare providers to help streamline the diagnostic process and alleviate current bottlenecks, while expanding collaboration with HME providers to efficiently and expeditiously support patients to start treatment. It further enhances the company’s ability to serve healthcare providers with integrated tools that improve care coordination, patient engagement, and outcomes.
“VirtuOx and Resmed are aligned in our focus to simplify healthcare and expand access,” said Steve Lica, CEO of VirtuOx. “Joining Resmed gives us the opportunity to scale our impact, reach and help more patients, and keep innovating on behalf of the providers and health systems we serve.”
The acquisition supports a growing demand for home-based care—driven by increased awareness, convenience, and digital innovation. It also creates opportunities to expand into adjacent areas such as insomnia, while deepening Resmed’s relationships with physicians, sleep labs, and home medical equipment providers.